[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 2,088 Item 6: 0 Item 7: 33,606,248 Item 8: 0 Item 9: 33,606,248 Item 11: 9.498% Item 12: HC Cusip #Y3197V101 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 33,606,248 Item 8: 0 Item 9: 33,606,248 Item 11: 9.498%]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 607,818 Item 6: 0 Item 7: 937,893 Item 8: 0 Item 9: 937,893 Item 11: 2.602% Item 12: HC Cusip #G25861108 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 937,893 Item 8: 0 Item 9: 937,893 Item 11: 2.602%]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 2,088 Item 6: 0 Item 7: 33,606,248 Item 8: 0 Item 9: 33,606,248 Item 11: 9.498% Item 12: HC Cusip #Y3197V101 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 33,606,248 Item 8: 0 Item 9: 33,606,248 Item 11: 9.498%]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 607,818 Item 6: 0 Item 7: 937,893 Item 8: 0 Item 9: 937,893 Item 11: 2.602% Item 12: HC Cusip #G25861108 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 937,893 Item 8: 0 Item 9: 937,893 Item 11: 2.602%]
[] [] [Joint Filing Agreement This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which shall together constitute the same agreement. Executed this 12th day of December, 2011. BERTELSMANN AG BERTELSMANN ASIA INVESTMENTS AG] [SCHEDULE 13D CHINA DISTANCE EDUCATION HOLDINGS LIMITED ORDINARY SHARES** AMERICAN DEPOSITARY SHARES 16944W104*** Wang Zhi 18 th Floor, Xueyuan International Tower copies to: Jenny Liu, Esq. Sheppard Mullin Richter & Hampton LLP November 18, 2008 If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and]
[filing.txt 1 13G/A]
[EX-16.1 2 v242898_ex16-1.htm] [ITEM 4.01]
[WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China December 12, 2011 VIA EMAIL AND ELECTRONIC TRANSMISSION Division of Corporate Finance Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: WuXi PharmaTech (Cayman) Inc. Form 20-F filed on April 27, 2011 (File No. 001-33623) Dear Mr. Rosenberg: Comment Letter This]
[filing.txt 1 13G/A]
[EX-16.1 2 v242898_ex16-1.htm] [ITEM 4.01]
